| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genes, Immunoglobulin | 49 | 2012 | 111 | 6.190 |
Why?
|
| Cytidine Deaminase | 18 | 2014 | 43 | 4.640 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 16 | 2014 | 32 | 4.320 |
Why?
|
| B-Lymphocytes | 55 | 2013 | 724 | 3.560 |
Why?
|
| Immunoglobulin lambda-Chains | 20 | 2013 | 42 | 2.120 |
Why?
|
| DNA-Binding Proteins | 16 | 2017 | 1208 | 1.880 |
Why?
|
| Immunoglobulin kappa-Chains | 32 | 2001 | 96 | 1.790 |
Why?
|
| Transgenes | 15 | 2007 | 180 | 1.650 |
Why?
|
| Immunoglobulin Variable Region | 22 | 2012 | 109 | 1.600 |
Why?
|
| Mutation | 30 | 2014 | 3968 | 1.490 |
Why?
|
| Immunoglobulin Light Chains | 23 | 2014 | 86 | 1.420 |
Why?
|
| DNA Repair | 12 | 2012 | 356 | 1.420 |
Why?
|
| Immunoglobulins | 21 | 2009 | 148 | 1.420 |
Why?
|
| Recombination, Genetic | 18 | 2007 | 439 | 1.400 |
Why?
|
| Mice | 116 | 2017 | 11352 | 1.370 |
Why?
|
| DNA | 32 | 2009 | 1294 | 1.310 |
Why?
|
| Immunoglobulin Heavy Chains | 21 | 2014 | 131 | 1.260 |
Why?
|
| Animals | 138 | 2017 | 26582 | 1.200 |
Why?
|
| Transcription, Genetic | 28 | 2013 | 1135 | 1.160 |
Why?
|
| Mice, Transgenic | 41 | 2006 | 1540 | 1.160 |
Why?
|
| Base Sequence | 45 | 2010 | 2330 | 1.130 |
Why?
|
| Immunoglobulin Constant Regions | 10 | 2006 | 21 | 1.020 |
Why?
|
| Enhancer Elements, Genetic | 12 | 2010 | 266 | 1.010 |
Why?
|
| Immunoglobulin Class Switching | 5 | 2007 | 37 | 0.940 |
Why?
|
| Transcription Factors | 11 | 2003 | 1565 | 0.930 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 8 | 1999 | 37 | 0.850 |
Why?
|
| DNA Methylation | 5 | 2014 | 628 | 0.830 |
Why?
|
| Cytosine Deaminase | 3 | 2005 | 9 | 0.810 |
Why?
|
| DNA Glycosylases | 3 | 2006 | 24 | 0.780 |
Why?
|
| Embryo, Mammalian | 3 | 2017 | 207 | 0.770 |
Why?
|
| Molecular Sequence Data | 29 | 2004 | 3030 | 0.730 |
Why?
|
| Immunoglobulin mu-Chains | 11 | 1999 | 18 | 0.700 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 9 | 2002 | 24 | 0.690 |
Why?
|
| Mice, Inbred C57BL | 21 | 2014 | 3092 | 0.660 |
Why?
|
| Cell Line | 30 | 2013 | 2468 | 0.660 |
Why?
|
| RNA Polymerase II | 2 | 2013 | 55 | 0.650 |
Why?
|
| Gene Expression Regulation | 22 | 2010 | 1920 | 0.650 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 623 | 0.630 |
Why?
|
| Spleen | 31 | 2003 | 430 | 0.620 |
Why?
|
| Embryonic Germ Cells | 1 | 2017 | 1 | 0.620 |
Why?
|
| Spermatids | 1 | 2017 | 5 | 0.620 |
Why?
|
| Transcriptional Activation | 4 | 2014 | 280 | 0.620 |
Why?
|
| Spermatogonia | 1 | 2017 | 13 | 0.620 |
Why?
|
| Base Pair Mismatch | 4 | 2006 | 27 | 0.600 |
Why?
|
| Immunoglobulin gamma-Chains | 6 | 1999 | 14 | 0.580 |
Why?
|
| Gene Targeting | 3 | 2014 | 72 | 0.570 |
Why?
|
| Oocytes | 1 | 2017 | 221 | 0.570 |
Why?
|
| Point Mutation | 6 | 2006 | 246 | 0.560 |
Why?
|
| Genes | 16 | 1984 | 305 | 0.550 |
Why?
|
| N-Glycosyl Hydrolases | 2 | 2007 | 7 | 0.540 |
Why?
|
| T-Lymphocytes | 14 | 2002 | 1195 | 0.530 |
Why?
|
| B-Lymphocyte Subsets | 4 | 2014 | 40 | 0.530 |
Why?
|
| Receptors, Antigen, B-Cell | 4 | 2006 | 113 | 0.530 |
Why?
|
| Mutagenesis, Insertional | 4 | 2001 | 111 | 0.520 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2001 | 645 | 0.500 |
Why?
|
| Nucleosomes | 2 | 2012 | 54 | 0.500 |
Why?
|
| Mice, Knockout | 12 | 2010 | 1924 | 0.500 |
Why?
|
| RNA, Messenger | 21 | 2013 | 1981 | 0.490 |
Why?
|
| Embryonic Development | 1 | 2014 | 74 | 0.470 |
Why?
|
| Transfection | 7 | 2001 | 896 | 0.460 |
Why?
|
| Cloning, Molecular | 15 | 2014 | 646 | 0.440 |
Why?
|
| Immunoglobulin Joining Region | 5 | 2002 | 13 | 0.430 |
Why?
|
| Chickens | 6 | 2013 | 212 | 0.420 |
Why?
|
| Lymphocyte Activation | 5 | 2014 | 728 | 0.410 |
Why?
|
| Cytosine | 3 | 2005 | 127 | 0.400 |
Why?
|
| Chromatin | 5 | 2005 | 380 | 0.390 |
Why?
|
| Gene Rearrangement | 5 | 1992 | 170 | 0.390 |
Why?
|
| Hematopoietic Stem Cells | 6 | 1999 | 292 | 0.370 |
Why?
|
| Promoter Regions, Genetic | 5 | 2001 | 937 | 0.370 |
Why?
|
| Hybridomas | 13 | 2001 | 74 | 0.350 |
Why?
|
| Lymphoid Tissue | 3 | 2002 | 57 | 0.340 |
Why?
|
| Immunoglobulin Switch Region | 4 | 2009 | 10 | 0.340 |
Why?
|
| DNA, Superhelical | 2 | 2009 | 16 | 0.340 |
Why?
|
| Immunoglobulin G | 9 | 1997 | 456 | 0.340 |
Why?
|
| Signal Transduction | 5 | 2006 | 3241 | 0.330 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2007 | 4 | 0.320 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 381 | 0.320 |
Why?
|
| Gene Conversion | 1 | 2007 | 25 | 0.320 |
Why?
|
| RNA | 11 | 1999 | 560 | 0.310 |
Why?
|
| Proteins | 2 | 2005 | 777 | 0.300 |
Why?
|
| Autoantibodies | 2 | 2002 | 267 | 0.300 |
Why?
|
| Antibody Diversity | 6 | 2000 | 25 | 0.300 |
Why?
|
| DNA Primers | 6 | 2007 | 543 | 0.300 |
Why?
|
| Blotting, Southern | 8 | 2007 | 129 | 0.300 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 5 | 1994 | 20 | 0.300 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 214 | 0.290 |
Why?
|
| Nucleic Acid Hybridization | 21 | 1988 | 245 | 0.280 |
Why?
|
| BRCA1 Protein | 1 | 2007 | 200 | 0.280 |
Why?
|
| Cell Differentiation | 14 | 2002 | 1458 | 0.280 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 49 | 0.270 |
Why?
|
| Immune Complex Diseases | 1 | 2005 | 19 | 0.260 |
Why?
|
| DNA Mismatch Repair | 3 | 2010 | 52 | 0.250 |
Why?
|
| Gene Silencing | 1 | 2005 | 172 | 0.250 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 1998 | 372 | 0.250 |
Why?
|
| Mice, Inbred DBA | 4 | 2014 | 148 | 0.250 |
Why?
|
| Protein Folding | 1 | 2006 | 282 | 0.250 |
Why?
|
| Models, Genetic | 9 | 2003 | 926 | 0.240 |
Why?
|
| Immunologic Memory | 3 | 2000 | 152 | 0.240 |
Why?
|
| Restriction Mapping | 6 | 2009 | 157 | 0.230 |
Why?
|
| Antibody Formation | 8 | 1989 | 171 | 0.230 |
Why?
|
| DNA Polymerase III | 1 | 2003 | 9 | 0.230 |
Why?
|
| Genes, myc | 2 | 2000 | 39 | 0.230 |
Why?
|
| Autoimmunity | 2 | 2002 | 160 | 0.230 |
Why?
|
| Chromosome Mapping | 9 | 2001 | 1074 | 0.220 |
Why?
|
| Kidney | 3 | 2007 | 1241 | 0.220 |
Why?
|
| Polymerase Chain Reaction | 8 | 1999 | 927 | 0.220 |
Why?
|
| Enzyme Activation | 3 | 2012 | 692 | 0.220 |
Why?
|
| Phosphorylcholine | 5 | 1989 | 28 | 0.210 |
Why?
|
| Stem Cells | 3 | 2005 | 351 | 0.210 |
Why?
|
| Ribosomal Proteins | 2 | 1998 | 43 | 0.200 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2001 | 25 | 0.200 |
Why?
|
| Plasmids | 5 | 2009 | 287 | 0.200 |
Why?
|
| Humans | 31 | 2014 | 86643 | 0.200 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 2 | 1999 | 20 | 0.200 |
Why?
|
| Chromosomes, Artificial | 1 | 2001 | 1 | 0.200 |
Why?
|
| Bacteriophage P1 | 1 | 2001 | 2 | 0.200 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2001 | 30 | 0.200 |
Why?
|
| Flow Cytometry | 6 | 2007 | 679 | 0.200 |
Why?
|
| Mice, Inbred Strains | 7 | 2005 | 307 | 0.200 |
Why?
|
| DNA, Single-Stranded | 2 | 2013 | 92 | 0.190 |
Why?
|
| Uracil-DNA Glycosidase | 3 | 2005 | 6 | 0.190 |
Why?
|
| Choline | 3 | 1989 | 23 | 0.190 |
Why?
|
| Chromosomes | 1 | 2000 | 96 | 0.180 |
Why?
|
| Organ Specificity | 3 | 2017 | 258 | 0.180 |
Why?
|
| Multiple Myeloma | 11 | 1998 | 307 | 0.180 |
Why?
|
| Bone Marrow Cells | 6 | 2002 | 253 | 0.180 |
Why?
|
| Immunoglobulin M | 7 | 1997 | 154 | 0.180 |
Why?
|
| Lymphocytes | 8 | 1995 | 464 | 0.180 |
Why?
|
| Genes, MHC Class II | 3 | 1987 | 30 | 0.180 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1999 | 17 | 0.180 |
Why?
|
| Methylation | 7 | 1995 | 251 | 0.180 |
Why?
|
| Introns | 2 | 1998 | 289 | 0.170 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 176 | 0.170 |
Why?
|
| Lymphocyte Count | 3 | 2006 | 94 | 0.170 |
Why?
|
| Viral Proteins | 1 | 2001 | 300 | 0.170 |
Why?
|
| Binding Sites | 5 | 2010 | 1098 | 0.170 |
Why?
|
| Dogfish | 1 | 1998 | 2 | 0.170 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1998 | 23 | 0.160 |
Why?
|
| Ampicillin Resistance | 2 | 2009 | 5 | 0.160 |
Why?
|
| Muscle Proteins | 1 | 1998 | 132 | 0.160 |
Why?
|
| Binding Sites, Antibody | 3 | 1982 | 49 | 0.160 |
Why?
|
| Genes, RAG-1 | 1 | 1997 | 13 | 0.160 |
Why?
|
| Cockayne Syndrome | 1 | 1997 | 4 | 0.160 |
Why?
|
| Fungal Proteins | 1 | 1998 | 141 | 0.160 |
Why?
|
| Xeroderma Pigmentosum | 1 | 1997 | 9 | 0.160 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 2 | 2010 | 8 | 0.150 |
Why?
|
| TCF Transcription Factors | 2 | 2010 | 23 | 0.150 |
Why?
|
| Mice, Inbred C3H | 2 | 2014 | 370 | 0.140 |
Why?
|
| Tissue Distribution | 2 | 2014 | 290 | 0.140 |
Why?
|
| Deamination | 2 | 2005 | 6 | 0.140 |
Why?
|
| Hematopoiesis | 1 | 1997 | 163 | 0.140 |
Why?
|
| Trans-Activators | 2 | 1996 | 429 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 3 | 2001 | 43 | 0.140 |
Why?
|
| Terminator Regions, Genetic | 2 | 2013 | 14 | 0.140 |
Why?
|
| Ectoderm | 1 | 1995 | 29 | 0.140 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1998 | 276 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 9 | 1998 | 1047 | 0.130 |
Why?
|
| Cells, Cultured | 5 | 2006 | 2818 | 0.130 |
Why?
|
| RNA Splicing | 2 | 2001 | 142 | 0.130 |
Why?
|
| DNA Restriction Enzymes | 9 | 1984 | 98 | 0.130 |
Why?
|
| Male | 15 | 2017 | 40965 | 0.130 |
Why?
|
| Germ Cells | 2 | 2001 | 126 | 0.120 |
Why?
|
| Zinc Fingers | 1 | 2014 | 56 | 0.120 |
Why?
|
| Crosses, Genetic | 4 | 2000 | 171 | 0.120 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 28 | 0.120 |
Why?
|
| Avian Proteins | 1 | 2013 | 18 | 0.120 |
Why?
|
| Homeodomain Proteins | 1 | 1997 | 536 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 1994 | 135 | 0.110 |
Why?
|
| Immune System | 1 | 1994 | 93 | 0.110 |
Why?
|
| Genetic Vectors | 2 | 2001 | 439 | 0.110 |
Why?
|
| Thymus Gland | 8 | 1984 | 195 | 0.110 |
Why?
|
| Female | 11 | 2017 | 44532 | 0.110 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 2000 | 47 | 0.110 |
Why?
|
| Cell Fusion | 2 | 1992 | 39 | 0.110 |
Why?
|
| Nucleic Acid Conformation | 3 | 2005 | 332 | 0.110 |
Why?
|
| Antibody-Producing Cells | 4 | 1980 | 16 | 0.110 |
Why?
|
| Mutagenesis | 2 | 2005 | 199 | 0.100 |
Why?
|
| Alleles | 6 | 2001 | 1128 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2012 | 69 | 0.100 |
Why?
|
| DNA, Neoplasm | 4 | 1981 | 265 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 4 | 1998 | 1041 | 0.100 |
Why?
|
| RNA Editing | 2 | 2003 | 34 | 0.100 |
Why?
|
| Amino Acid Sequence | 5 | 2001 | 2062 | 0.100 |
Why?
|
| DNA Probes | 3 | 2003 | 77 | 0.100 |
Why?
|
| Writing | 1 | 1991 | 29 | 0.100 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2002 | 80 | 0.100 |
Why?
|
| Escherichia coli | 3 | 2004 | 597 | 0.100 |
Why?
|
| DNA Replication | 1 | 1991 | 164 | 0.100 |
Why?
|
| Peyer's Patches | 2 | 2003 | 18 | 0.100 |
Why?
|
| Thymosin | 1 | 1990 | 6 | 0.100 |
Why?
|
| Gene Expression | 4 | 2001 | 1284 | 0.090 |
Why?
|
| Immunoglobulin J-Chains | 2 | 1987 | 12 | 0.090 |
Why?
|
| Bone Marrow | 4 | 1997 | 435 | 0.090 |
Why?
|
| Research | 1 | 1991 | 253 | 0.090 |
Why?
|
| Protein Biosynthesis | 6 | 1979 | 378 | 0.090 |
Why?
|
| TATA Box | 2 | 2000 | 11 | 0.090 |
Why?
|
| Multigene Family | 2 | 2002 | 202 | 0.090 |
Why?
|
| Uracil | 1 | 2009 | 72 | 0.090 |
Why?
|
| Sheep | 10 | 1998 | 239 | 0.090 |
Why?
|
| Plasmacytoma | 8 | 1984 | 34 | 0.090 |
Why?
|
| Mice, Mutant Strains | 3 | 1986 | 229 | 0.080 |
Why?
|
| Serine | 2 | 2007 | 99 | 0.080 |
Why?
|
| Chromosome Deletion | 2 | 1987 | 229 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1384 | 0.080 |
Why?
|
| Species Specificity | 5 | 1995 | 678 | 0.080 |
Why?
|
| Antibodies, Bacterial | 1 | 1988 | 95 | 0.080 |
Why?
|
| Pedigree | 3 | 1998 | 966 | 0.080 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2007 | 66 | 0.080 |
Why?
|
| Protein Binding | 2 | 2003 | 1456 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 1999 | 189 | 0.070 |
Why?
|
| Histones | 1 | 2009 | 311 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1988 | 194 | 0.070 |
Why?
|
| Genetic Linkage | 3 | 2000 | 623 | 0.070 |
Why?
|
| Neoplasm Proteins | 2 | 2000 | 532 | 0.070 |
Why?
|
| Kanamycin Resistance | 1 | 2005 | 3 | 0.070 |
Why?
|
| Deoxyribonucleases | 3 | 1981 | 27 | 0.070 |
Why?
|
| Fibroblasts | 3 | 1999 | 729 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2007 | 782 | 0.070 |
Why?
|
| Sulfites | 1 | 2005 | 26 | 0.070 |
Why?
|
| Transformation, Genetic | 2 | 2001 | 40 | 0.070 |
Why?
|
| Sequence Analysis | 2 | 1996 | 26 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2006 | 80 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 879 | 0.070 |
Why?
|
| Mice, SCID | 2 | 1999 | 252 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2007 | 1106 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 133 | 0.060 |
Why?
|
| Retroviridae Proteins, Oncogenic | 2 | 1995 | 9 | 0.060 |
Why?
|
| Cytidine | 1 | 2004 | 17 | 0.060 |
Why?
|
| Genetic Engineering | 4 | 1987 | 114 | 0.060 |
Why?
|
| Deoxyribonuclease I | 3 | 1992 | 28 | 0.060 |
Why?
|
| Feedback | 3 | 1991 | 133 | 0.060 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 2003 | 5 | 0.060 |
Why?
|
| Exodeoxyribonucleases | 1 | 2003 | 14 | 0.060 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2002 | 36 | 0.060 |
Why?
|
| 5-Methylcytosine | 2 | 1995 | 112 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 31 | 0.060 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2002 | 20 | 0.060 |
Why?
|
| Fas Ligand Protein | 1 | 2002 | 49 | 0.060 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2002 | 44 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 38 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 1997 | 526 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 1993 | 177 | 0.050 |
Why?
|
| Chemokines | 1 | 2002 | 73 | 0.050 |
Why?
|
| Germinal Center | 1 | 2002 | 55 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1998 | 557 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 1993 | 145 | 0.050 |
Why?
|
| Deoxycytidine | 1 | 2003 | 237 | 0.050 |
Why?
|
| Valine | 1 | 2002 | 69 | 0.050 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 86 | 0.050 |
Why?
|
| Glycine | 1 | 2002 | 92 | 0.050 |
Why?
|
| Microscopy, Electron | 4 | 1998 | 503 | 0.050 |
Why?
|
| Autoantigens | 1 | 2002 | 127 | 0.050 |
Why?
|
| RNA Polymerase III | 1 | 2001 | 7 | 0.050 |
Why?
|
| Neomycin | 1 | 2001 | 7 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 279 | 0.050 |
Why?
|
| Artificial Gene Fusion | 1 | 2001 | 4 | 0.050 |
Why?
|
| Endonucleases | 1 | 1981 | 21 | 0.050 |
Why?
|
| Immunization | 3 | 1998 | 158 | 0.050 |
Why?
|
| Kinetics | 8 | 1988 | 1513 | 0.050 |
Why?
|
| Erythrocytes | 10 | 1972 | 255 | 0.050 |
Why?
|
| Integrases | 1 | 2001 | 59 | 0.050 |
Why?
|
| TATA-Box Binding Protein | 1 | 2000 | 6 | 0.050 |
Why?
|
| Liver | 4 | 1994 | 1230 | 0.050 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2000 | 33 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2002 | 241 | 0.050 |
Why?
|
| Immunity | 1 | 1981 | 136 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 428 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2000 | 145 | 0.050 |
Why?
|
| Plasma Cells | 4 | 1969 | 80 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 736 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 1999 | 52 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2001 | 476 | 0.040 |
Why?
|
| Carrier Proteins | 3 | 1999 | 673 | 0.040 |
Why?
|
| Codon, Terminator | 1 | 1999 | 21 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2002 | 1286 | 0.040 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 1999 | 16 | 0.040 |
Why?
|
| MutL Protein Homolog 1 | 1 | 1999 | 33 | 0.040 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1979 | 4 | 0.040 |
Why?
|
| CpG Islands | 1 | 1999 | 151 | 0.040 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1999 | 16 | 0.040 |
Why?
|
| MEF2 Transcription Factors | 1 | 1998 | 9 | 0.040 |
Why?
|
| Myogenic Regulatory Factors | 1 | 1998 | 4 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1998 | 28 | 0.040 |
Why?
|
| Cell Movement | 1 | 2002 | 758 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 1998 | 94 | 0.040 |
Why?
|
| Microsomes | 3 | 1974 | 35 | 0.040 |
Why?
|
| Peanut Agglutinin | 1 | 1998 | 3 | 0.040 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1998 | 30 | 0.040 |
Why?
|
| Nephrons | 1 | 1998 | 18 | 0.040 |
Why?
|
| Blood Group Antigens | 1 | 1998 | 17 | 0.040 |
Why?
|
| Urea | 1 | 1998 | 57 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 1998 | 46 | 0.040 |
Why?
|
| MutS Homolog 2 Protein | 1 | 1998 | 30 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1992 | 135 | 0.040 |
Why?
|
| Neoplasms, Experimental | 4 | 1981 | 269 | 0.040 |
Why?
|
| Interferon Regulatory Factors | 2 | 1996 | 67 | 0.040 |
Why?
|
| alpha-Fetoproteins | 1 | 1998 | 45 | 0.040 |
Why?
|
| Clone Cells | 2 | 1997 | 213 | 0.040 |
Why?
|
| Leukemia, B-Cell | 1 | 1998 | 23 | 0.040 |
Why?
|
| Microcirculation | 1 | 1998 | 106 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 1998 | 268 | 0.040 |
Why?
|
| Globins | 1 | 1977 | 31 | 0.040 |
Why?
|
| Goats | 1 | 1997 | 18 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1998 | 393 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 1997 | 18 | 0.040 |
Why?
|
| Base Composition | 1 | 1997 | 35 | 0.040 |
Why?
|
| Genes, Switch | 1 | 1997 | 8 | 0.040 |
Why?
|
| Macrophages | 5 | 1969 | 554 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1999 | 302 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 154 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 1997 | 30 | 0.040 |
Why?
|
| Genes, bcl-2 | 1 | 1997 | 16 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 3 | 1972 | 23 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 1998 | 265 | 0.040 |
Why?
|
| Gene Deletion | 1 | 1998 | 329 | 0.040 |
Why?
|
| Lymphoma, B-Cell | 1 | 1998 | 103 | 0.040 |
Why?
|
| Nucleic Acid Denaturation | 4 | 1979 | 34 | 0.040 |
Why?
|
| Codon | 1 | 1997 | 124 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 1997 | 80 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 1997 | 114 | 0.040 |
Why?
|
| Antibodies | 3 | 1969 | 350 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 1997 | 205 | 0.040 |
Why?
|
| RNA, Neoplasm | 2 | 1974 | 87 | 0.040 |
Why?
|
| Lymph Nodes | 4 | 1970 | 533 | 0.040 |
Why?
|
| Ribosomes | 2 | 1977 | 111 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 1997 | 211 | 0.040 |
Why?
|
| Molecular Weight | 3 | 1983 | 332 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 376 | 0.030 |
Why?
|
| Models, Biological | 1 | 2003 | 1749 | 0.030 |
Why?
|
| Time Factors | 4 | 1999 | 5210 | 0.030 |
Why?
|
| Apoptosis | 1 | 2002 | 1683 | 0.030 |
Why?
|
| Spermatozoa | 1 | 1995 | 62 | 0.030 |
Why?
|
| Biological Evolution | 1 | 1982 | 919 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 696 | 0.030 |
Why?
|
| Radiation Effects | 2 | 1972 | 28 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1995 | 351 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1988 | 316 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 2705 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 1993 | 25 | 0.030 |
Why?
|
| Homozygote | 1 | 1994 | 200 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 853 | 0.030 |
Why?
|
| Cell Separation | 1 | 1994 | 196 | 0.030 |
Why?
|
| Myeloma Proteins | 2 | 1986 | 32 | 0.030 |
Why?
|
| Hemolysin Proteins | 2 | 1972 | 34 | 0.030 |
Why?
|
| Tritium | 5 | 1974 | 133 | 0.030 |
Why?
|
| Polyribosomes | 1 | 1972 | 18 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 1993 | 95 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1998 | 1204 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 1998 | 813 | 0.030 |
Why?
|
| Scientific Misconduct | 1 | 1991 | 10 | 0.030 |
Why?
|
| Fetus | 1 | 1992 | 226 | 0.030 |
Why?
|
| Metallothionein | 1 | 1991 | 13 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 1991 | 37 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1991 | 71 | 0.020 |
Why?
|
| Laboratories | 1 | 1991 | 43 | 0.020 |
Why?
|
| Lymphoma | 2 | 1984 | 262 | 0.020 |
Why?
|
| Mosaicism | 1 | 1991 | 67 | 0.020 |
Why?
|
| Hybrid Cells | 2 | 1980 | 72 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 1993 | 337 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1991 | 122 | 0.020 |
Why?
|
| Cosmids | 1 | 1990 | 22 | 0.020 |
Why?
|
| Concanavalin A | 2 | 1980 | 52 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1997 | 3612 | 0.020 |
Why?
|
| Publishing | 1 | 1991 | 90 | 0.020 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1990 | 14 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1990 | 91 | 0.020 |
Why?
|
| Puromycin | 1 | 1969 | 10 | 0.020 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1989 | 12 | 0.020 |
Why?
|
| Fluorides | 1 | 1969 | 13 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1989 | 101 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1989 | 49 | 0.020 |
Why?
|
| Haptens | 1 | 1988 | 9 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 1988 | 10 | 0.020 |
Why?
|
| Nucleotide Mapping | 1 | 1988 | 7 | 0.020 |
Why?
|
| Adult | 2 | 1998 | 25648 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1988 | 158 | 0.020 |
Why?
|
| Hemolytic Plaque Technique | 3 | 1972 | 12 | 0.020 |
Why?
|
| Pentosyltransferases | 1 | 1987 | 35 | 0.020 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1987 | 35 | 0.020 |
Why?
|
| Drug Stability | 2 | 1977 | 48 | 0.020 |
Why?
|
| Chimera | 1 | 1987 | 56 | 0.020 |
Why?
|
| Methods | 3 | 1972 | 152 | 0.020 |
Why?
|
| Proinsulin | 1 | 1987 | 124 | 0.020 |
Why?
|
| Protein Precursors | 1 | 1987 | 143 | 0.020 |
Why?
|
| NF-kappa B | 1 | 1990 | 444 | 0.020 |
Why?
|
| Child | 1 | 1997 | 6927 | 0.020 |
Why?
|
| Abelson murine leukemia virus | 1 | 1985 | 3 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 1985 | 40 | 0.020 |
Why?
|
| Immunoelectrophoresis | 1 | 1965 | 19 | 0.020 |
Why?
|
| Coagulants | 1 | 1965 | 7 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 1965 | 46 | 0.020 |
Why?
|
| Temperature | 2 | 1977 | 396 | 0.020 |
Why?
|
| Fibrinogen | 1 | 1965 | 56 | 0.020 |
Why?
|
| Umbilical Cord | 1 | 1965 | 40 | 0.020 |
Why?
|
| Adolescent | 1 | 1997 | 8981 | 0.020 |
Why?
|
| Hot Temperature | 2 | 1976 | 206 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1983 | 16 | 0.020 |
Why?
|
| Polynucleotides | 2 | 1974 | 17 | 0.020 |
Why?
|
| Uridine | 3 | 1973 | 56 | 0.020 |
Why?
|
| Salmonella typhi | 3 | 1972 | 7 | 0.020 |
Why?
|
| Microinjections | 1 | 1983 | 70 | 0.010 |
Why?
|
| Rats | 1 | 1990 | 3990 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1973 | 112 | 0.010 |
Why?
|
| Phenotype | 2 | 1989 | 2378 | 0.010 |
Why?
|
| Cricetinae | 1 | 1983 | 560 | 0.010 |
Why?
|
| Insulin | 1 | 1987 | 1160 | 0.010 |
Why?
|
| Bacteriophage lambda | 1 | 1981 | 24 | 0.010 |
Why?
|
| Poly A | 1 | 1981 | 23 | 0.010 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1980 | 2 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1980 | 67 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1980 | 93 | 0.010 |
Why?
|
| Immune Sera | 2 | 1970 | 52 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1980 | 22 | 0.010 |
Why?
|
| Methionine | 1 | 1980 | 66 | 0.010 |
Why?
|
| Middle Aged | 1 | 1998 | 25028 | 0.010 |
Why?
|
| Carcinoma, Krebs 2 | 1 | 1978 | 1 | 0.010 |
Why?
|
| United States | 1 | 1991 | 6672 | 0.010 |
Why?
|
| Guinea Pigs | 3 | 1967 | 171 | 0.010 |
Why?
|
| Freund's Adjuvant | 2 | 1967 | 26 | 0.010 |
Why?
|
| Interferon-Stimulated Gene Factor 3, gamma Subunit | 1 | 1996 | 3 | 0.010 |
Why?
|
| Interferon-Stimulated Gene Factor 3 | 1 | 1996 | 3 | 0.010 |
Why?
|
| Thymoma | 1 | 1976 | 30 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 1996 | 233 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 148 | 0.010 |
Why?
|
| Antigens | 3 | 1972 | 228 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1996 | 444 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1974 | 51 | 0.010 |
Why?
|
| Haploidy | 1 | 1974 | 31 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1974 | 268 | 0.010 |
Why?
|
| Poly U | 1 | 1973 | 6 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1996 | 881 | 0.010 |
Why?
|
| Ultrafiltration | 1 | 1973 | 13 | 0.010 |
Why?
|
| Half-Life | 1 | 1973 | 96 | 0.010 |
Why?
|
| RNA, Ribosomal | 1 | 1973 | 60 | 0.010 |
Why?
|
| Plant Proteins | 1 | 1974 | 132 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 1996 | 403 | 0.010 |
Why?
|
| Mathematics | 1 | 1973 | 190 | 0.010 |
Why?
|
| Plants | 1 | 1974 | 112 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 1973 | 63 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1972 | 71 | 0.010 |
Why?
|
| Membranes | 1 | 1972 | 36 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1972 | 181 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1973 | 281 | 0.010 |
Why?
|
| Phosphorus Isotopes | 1 | 1972 | 24 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1972 | 92 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 1972 | 134 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1972 | 129 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1970 | 989 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 1970 | 23 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1970 | 37 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1970 | 106 | 0.010 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1969 | 4 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1969 | 29 | 0.010 |
Why?
|
| Hemocyanins | 1 | 1989 | 7 | 0.010 |
Why?
|
| Leucine | 1 | 1969 | 67 | 0.010 |
Why?
|
| Peritoneum | 1 | 1969 | 57 | 0.010 |
Why?
|
| Agglutination Tests | 1 | 1968 | 11 | 0.010 |
Why?
|
| Peptides | 1 | 1972 | 639 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1968 | 35 | 0.010 |
Why?
|
| Cell Communication | 1 | 1988 | 194 | 0.000 |
Why?
|
| Tissue Extracts | 1 | 1967 | 24 | 0.000 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1967 | 25 | 0.000 |
Why?
|
| Hemagglutination Tests | 1 | 1967 | 11 | 0.000 |
Why?
|
| Immunity, Active | 1 | 1967 | 9 | 0.000 |
Why?
|
| Poultry | 1 | 1967 | 22 | 0.000 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1967 | 31 | 0.000 |
Why?
|
| Microscopy | 1 | 1967 | 87 | 0.000 |
Why?
|
| Autoradiography | 1 | 1980 | 69 | 0.000 |
Why?
|
| Pregnancy | 1 | 1965 | 2894 | 0.000 |
Why?
|
| Lung | 1 | 1968 | 1170 | 0.000 |
Why?
|